- Open Access
Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
Critical Care volume 19, Article number: 386 (2015)
Regular measurement of systemic and post-filter ionized calcium (iCa) concentrations is imperative to correctly handle regional citrate anticoagulation dose during continuous renal replacement therapy (CRRT). Keeping post-filter iCa within a tight range guarantees optimal circuit function and enhances filter life span [1, 2], whereas a decrease in plasma iCa, with subsequent elevation of the total-to-ionized plasma calcium ratio, can predict systemic citrate accumulation .
The new findings (published recently in Critical Care) of Schwarzer et al. expose an alarming inaccuracy for measuring post-filter iCa with currently available blood gas analyzers . This precludes adequate control of citrate flow and raises evident functional and safety issues. On the other hand, Schwarzer et al. found good concordance between all evaluated analyzers for measuring systemic iCa levels . However, the total-to-ionized plasma calcium ratio has occasionally been shown to be a relatively weak indirect marker for citrate accumulation or intoxication [1, 2]. Direct measurement of citrate systemic concentrations could overcome these iCa-related shortcomings. In this perspective, compelling evidence was provided by Italian investigators who adapted a commercially available citrate analyzing kit for measuring systemic and also filter citrate concentrations . Preliminary experience in septic shock patients with liver dysfunction undergoing CRRT suggested a potential clinical use but needs confirmation in a larger and more heterogeneous patient population.
Continuous renal replacement therapy
Egi M, Naka T, Bellomo R, Cole L, French C, Trethewy C, et al. A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration. Int J Artif Organs. 2005;28:1211–8.
Jacobs R, Honoré PM, Bagshaw SM, Diltoer M, Spapen HD. Citrate formulation determines filter lifespan during continuous veno-venous hemofiltration: a prospective cohort study. Blood Purif. 2015;40:194–202.
Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med. 2001;29:748–52.
Schwarzer P, Kuhn SO, Stracke S, Gründling M, Knigge S, Selleng S, et al. Discrepant post filter ionized calcium concentrations by common blood gas analyzers in CRRT using regional citrate anticoagulation. Crit Care. 2015;19:321.
Mariano F, Morselli M, Bergamo D, Hollo Z, Scella S, Maio M, et al. Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients. Nephrol Dial Transplant. 2011;26:3882–8.
The authors declare that they have no competing interests.
PMH and HDS designed and helped draft the manuscript. RJ, IH, EDW and VVG helped draft the manuscript. All authors read and approved the final manuscript.
See related research by Schwarzer et al., http://www.ccforum.com/content/19/1/321
About this article
Cite this article
Honore, P.M., Jacobs, R., Hendrickx, I. et al. Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?. Crit Care 19, 386 (2015). https://doi.org/10.1186/s13054-015-1103-6
- Continuous Renal Replacement Therapy
- Septic Shock Patient
- Citrate Concentration
- Heterogeneous Patient Population
- Optimal Circuit